Bicycle Therapeutics (BCYC) Appoints Travis Thompson as CFO Following Leadership Transitions

Bicycle Therapeutics (NASDAQ:BCYC) is one of the best get-rich-quick stocks to buy according to hedge funds. On February 3, Bicycle Therapeutics announced several key leadership transitions as the company enters a new phase of innovation for its proprietary bicyclic peptide technology. Travis Thompson, who joined the firm in 2018 and previously served as senior vice president and chief accounting officer, has been appointed as the new chief financial officer. He succeeds Alethia Young, who will transition ...